• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home Wellness

Wellness Check: Exercise

byNicholas Ng Fat HingandAvneesh Bhangu
April 28, 2022
in Wellness
Reading Time: 5 mins read
Share on FacebookShare on TwitterShare on LinkedIn

2 Minute Medicine is pleased to announce that we are launching Wellness Check, a new series dedicated to exploring new research evidence focused on wellness. Each week, we will report on articles examining different aspects of wellness, including (but not limited to) nutrition, sleep, reproductive health, substance use and mental health. This week, we explore the latest evidence-based updates in exercise.

Increased physical activity is a long-term protective factor for dementia

1. Physical activity was significantly associated with a decreased incidence of all-cause dementia and Alzheimer’s disease, irrespective of follow-up length, baseline age and study quality.

2. Physical activity was found to be a protective factor for all-cause dementia and Alzheimer’s disease, even in follow-ups longer than 20 years.

Evidence Rating Level: 1 (Excellent)

Physical activity (PA) is an important modifiable risk factor in the prevention and incidence of dementia. Although many meta-analyses have previously investigated this relationship, they have often lacked rigorous quality assessments or have short follow-up times. As a result, the present systematic review and meta-analysis examines the influence of mid-life PA as a protective factor of all-cause dementia, Alzheimer’s disease and vascular dementia.

RELATED REPORTS

Medicaid status, race and ethnicity are independently associated with increased odds of severe maternal morbidity

Midline catheters may reduce catheter-related bloodstream infections compared with peripherally inserted central catheters in intensive care unit patients

From 16,324 identified articles, 58 articles were included (n=257 983) from database inception to October 2021. Studies were included if they had a baseline measure of PA and a follow-up longer than 1 year. Studies were excluded if participants had a specific disease at baseline or had established mild cognitive impairment/dementia at baseline. Quality assessment was performed using a tool that authors developed specifically for the present study. Statistical analyses were performed using pooled effect sizes, dose-response analysis and funnel plots.

Results demonstrated that physical activity was significantly associated with a decreased incidence of all-cause dementia and Alzheimer’s disease, irrespective of follow-up length, baseline age, and study quality. Furthermore, physical activity was found to be a protective factor for all-cause dementia and Alzheimer’s disease, even in follow-ups longer than 20 years. However. the study was limited by the lack of high-quality studies and the limited reports of vascular dementia as an outcome. Nonetheless, the present study provides a unique contribution to the literature by demonstrating a significant association between PA and dementia during longer follow-ups than earlier analyses.

 

High physical activity may have a role in increasing coronary artery calcification

1. Participants in the high physical activity trajectory group had a higher risk of coronary artery calcification progression compared to those in the low physical activity trajectory group after adjusting for traditional cardiovascular risk factors.

2. The high physical activity trajectory group was not associated with an increased risk of incident cardiovascular events.

Evidence Rating Level: 2 (Good)

Recent evidence demonstrates that there may be a threshold beyond which the cardiovascular benefits of physical activity (PA) are lost. Furthermore, prior studies have not explored the relationship of PA trajectories from young adulthood onwards with respect to coronary artery calcification (CAC) and the development of cardiovascular disease (CVD) later in life. As a result, the aim of the present study was to describe longitudinal changes in PA levels over a 25-year span among individuals free of CVD and evaluate subsequent CAC progression and incident CVD events.

From 1985-1986, 2497 participants (aged 18-30) were included from the Coronary Artery Risk Development in Young Adults (CARDIA) study. All study participants were included at year 15. Participants were excluded if they had missing baseline CAC data or had missing covariates of interest. PA levels were examined between years 0 and 25 through a self-reported questionnaire. CAC was measured at years 15, 20 and 25. Long term PA trajectories (low, moderate, high) were determined by latent class modelling.

The results demonstrated that participants in the high physical activity (PA) trajectory group had a higher risk of coronary artery calcification (CAC) progression compared to those in the low PA trajectory group. The high PA trajectory group did not have an increased risk of incident CVD events. However, the study was limited by the relatively low number of total participants and incident CVD events in the high PA group, which may affect the results. Nonetheless, the study design allowed for a unique opportunity to examine the association between PA in early adulthood and CVD outcomes in midlife.

 

Increases in muscle-strengthening activities may reduce mortality risk and certain diseases

1. Muscle-strengthening activities (MSA) were associated with a lower risk of cardiovascular disease (CVD), total cancer, diabetes, lung cancer and all-cause mortality, independent of aerobic activities.

2. The maximum risk reduction was obtained at around 30-60 minutes/week.

Evidence Rating Level: 2 (Good)

The recent World Health Organization guidelines recommend that adults should perform MSA at least 2 days per week. Compared with aerobic activities, MSA has not been investigated as frequently in terms of its influence on preventing premature death and non-communicable diseases (NCDs). As a result, the purpose of the present systematic review and meta-analysis of prospective cohort studies was to investigate the association of MSA on the risk of mortality and NCDs among adults.

From 1252 identified records, 29 studies (n = 263,058 participants) were included from database inception to October 2020. Eligible studies had a prospective observational design of adults and examined the influence of MSA on any health outcome. Studies were excluded if participants had severe baseline health conditions (e.g. cancer or disability). Study quality was assessed using a modification of the Newcastle-Ottawa Scale (NOS) for Quality Assessment of Prospective Cohort Studies. A dose-response meta-analysis was used to investigate the influence of MSA on health outcomes.

Results demonstrated that MSA were associated with a lower risk of CVD, total cancer, diabetes, lung cancer and all-cause mortality independent of aerobic activities. Furthermore, the maximum risk reduction was obtained at around 30-60 minutes/week. However, the study was limited by the small number of included studies which precluded the ability to perform subgroup analyses. Despite this, the present study suggests that performing MSA may provide benefit in reducing the risk of NCDs independent of aerobic activity.

 

Exercise interventions are currently being poorly reported in the literature 

1. In this overview of systematic reviews, characteristics of exercise interventions such as “when”, “how much” as well as detailed descriptions were poorly reported across a range of studies.

2. Furthermore, the quality of systematic reviews included in this study ranged from critically low to moderate in quality.

Evidence Rating Level: 2 (Good)

Compared with trials of medicines, the methodologies of exercise trials tend to be poorly reported. Tools such as the Consensus on Exercise reporting Template (CERT) and the Template for Intervention Description and Replication (TIDieR) were developed to improve poor reporting. Though many systematic reviews have investigated the quality of reporting of exercise interventions, these have not yet been synthesized. As a result, the aim of the present systematic review is to determine how well exercise interventions have been reported in the literature.

From 7804 identified records, 28 systematic reviews (1467 studies comprising 1724 interventions) were included from database inception up to July 2021. Studies were included if they primarily assessed the quality of exercise intervention reporting using either the CERT or TIDieR tools. Review quality was assessed using a modified version of A Measurement Tool to Assess systematic Reviews (AMSTAR 2). Data was synthesized using simple descriptive statistics for each item of each relevant tool.

The results demonstrated that characteristics of exercise interventions described using CERT or TIDieR (such as “when”, “how much” as well as detailed descriptions) were poorly reported across a range of studies. Furthermore, the quality of systematic reviews ranged from critically low to moderate in quality. However, the study was limited by the fact that the authors chose to only include data extracted from the main articles and supplemental materials, rather than actively seeking out protocols or contacting trial authors which may have impacted the completeness of the reporting. Nonetheless, the present study sheds light on the need for high quality reporting in order to improve translation in clinical settings.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: coronary arterycoronary artery calcificationdementiaexercisemortalityphysical activitystrength trainingwellness
Previous Post

#VisualAbstract: Trastuzumab does not improve survival in patients with esophageal adenocarcinoma with HER2 overexpression

Next Post

#VisualAbstract: Neoadjuvant nivolumab plus chemotherapy increases event-free survival in resectable non-small-cell lung cancer

RelatedReports

A pregnant woman consults with a healthcare provider, who is holding a clipboard and discussing maternal health topics. A weight scale and imagery of a fetus are also present.
Cardiology

Medicaid status, race and ethnicity are independently associated with increased odds of severe maternal morbidity

November 6, 2026
IV line infection collage: a winged IV catheter, a clear dressing, three blue circles along a ribbon and round bacteria
Cardiology

Midline catheters may reduce catheter-related bloodstream infections compared with peripherally inserted central catheters in intensive care unit patients

November 5, 2026
Emergency care collage: an empty hospital stretcher with a pillow and sheet before blue double doors with round windows
Chronic Disease

Non-inpatient care settings may offer alternatives to inpatient beds for select patients

November 6, 2026
Migraine collage of a young woman resting with eyes closed beside a teal zigzag ribbon, a curtained window and water
Weekly Rewinds

2 Minute Medicine Rewind November 2, 2026

November 2, 2026
Next Post
#VisualAbstract: Neoadjuvant nivolumab plus chemotherapy increases event-free survival in resectable non-small-cell lung cancer

#VisualAbstract: Neoadjuvant nivolumab plus chemotherapy increases event-free survival in resectable non-small-cell lung cancer

Antenatal corticosteroids may affect neurodevelopment differently based on gestational age

Admission may not be needed following sleep apnea surgery

Weight loss and lifestyle changes may improve symptoms of obstructive sleep apnea in overweight men

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 101-PGC-005 improved hospitalized patients with COVID-19 faster than systemic dexamethasone in topline phase 2/3 results
  • 2MM: Pharma Roundup – First DNA therapy approved which could reduce airway surgeries, novel siRNA targets dual lipid pathways, GLP-1s outperform metformin in prediabetes, and Zolgensma tumor risks under FDA review
  • Tafolecimab monotherapy reduced low-density lipoprotein cholesterol by more than 60% at week 12 in phase 3 CREDIT-5 results
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.